Difference in Acute Responses of Vascular Function to Moderate-intensity and High-intensity Interval Training in Healthy and Prehypertensive Individuals
ACT-ON-ACUTE
3 other identifiers
interventional
45
1 country
1
Brief Summary
In this study, the investigators will evaluate acute changes in vascular function measures after moderate-intensity continuous and high-intensity interval exercise in healthy and prehypertensive individuals. Participants will be subjected to three separate visits: control condition (30 min rest), moderate-intensity continuous exercise, and high-intensity interval exercise. The investigators will measure aerobic capacity using a cardiopulmonary exercise test (CPET) using indirect gas-exchange to derive subsequent exercise intensity and maximal oxygen uptake. The investigators will evaluate different measures of vascular function (Pulse-wave velocity, Flow-mediated slowing, microvascular function) before and after each condition. The study will involve two groups of participants: healthy individuals and prehypertensive individuals. The investigators aim to establish the reliability and validity of less-established methods of vascular function assessment (flow-mediated slowing and microvascular function) against established measures (pulse-wave velocity). The acute response of vascular function to different exercise intensities has not yet been thoroughly researched using the aforementioned measures in individuals with similar characteristics to the proposed study cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2025
CompletedStudy Start
First participant enrolled
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedDecember 22, 2025
December 1, 2025
10 months
June 20, 2025
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Arterial stiffness
Arterial stiffness will be measured by pulse wave velocity
At the beginning of each visit (T0) and immediately after each acute stimulus (T1)
Microvascular function
Microvascular function will be mesured using near-infrared spectroscopy during and after a 5-minute occlusion of the brachial artery.
At the beginning of each visit (T0) and immediately after each acute stimulus (T1)
Flow-mediated slowing
Flow-mediated slowing will be measured by pulse wave velocity deceleration after occlusion of the brachial artery.
At the beginning of each visit (T0) and immediately after each acute stimulus (T1)
Secondary Outcomes (3)
Aerobic capacity
Baseline
Blood pressure
Baseline
Blood markers
At the beginning of each visit (T0) and immediately after each acute stimulus (T1)
Study Arms (2)
Normotensive
PLACEBO COMPARATORNormotensives with ambulatory blood pressure measurements within the optimal range according to the 2023 ESH guidelines
Prehypertensive
ACTIVE COMPARATORPrehypertensives with blood pressure within 120-139 mmHg systolic and/or 80-89 diastolic.
Interventions
Eligibility Criteria
You may qualify if:
- years of age, BMI \< 30, blood pressure (BP) within the optimal range according to the latest ESH guidelines (\< 120 mmHg systolic and/or \< 80 mmHg diastolic BP)
- Sedentary or low active according to the Global Physical Activity Questionnaire (GPAQ) (Armstrong \& Bull, 2006; Lim et al., 2012)
- No prescribed medication and absence of chronic diseases
- years of age, BMI \< 30
- Diagnosed prehypertension by a clinican from the Hypertension clinic, University clinical centre of Ljubljana using established criteria
- Sedentary or low or moderately active according to the Global Physical Activity Questionnaire (GPAQ)
- No prescribed medication and absence of chronic diseases
You may not qualify if:
- Blood pressure out of the optimal range (normotensives)
- High level of phyisical activity (moderate or high active according to GPAQ)
- Hypotension
- Chronic diseases
- Prescribed medication
- Lower extremity injury in the last six months
- Menopause
- Absence of normal menstrual cycle
- Pregnancy
- Smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ljubljana, Faculty of sport
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 20, 2025
First Posted
July 2, 2025
Study Start
June 24, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
December 22, 2025
Record last verified: 2025-12